Merck Opens Production Facility Exclusively for Meglumine in Spain
MilliporeSigma | January 17, 2017
Merck, a leading science and technology company, today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.